APA (7th ed.) Citation

Sidonio, R. F., Casiano, S., Falk, A., Altincatal, A., Katragadda, S., Santagostino, E., & Windyga, J. (2023). Pharmacokinetic parameters of recombinant factor IX Fc fusion protein are not influenced by factor IX antigen levels in subjects from the Phase 3 B‐LONG trial. Haemophilia : the official journal of the World Federation of Hemophilia, 29(1), 404-407. https://doi.org/10.1111/hae.14727

Chicago Style (17th ed.) Citation

Sidonio, Robert F., Sandra Casiano, Aletta Falk, Arman Altincatal, Suresh Katragadda, Elena Santagostino, and Jerzy Windyga. "Pharmacokinetic Parameters of Recombinant Factor IX Fc Fusion Protein Are Not Influenced by Factor IX Antigen Levels in Subjects from the Phase 3 B‐LONG Trial." Haemophilia : The Official Journal of the World Federation of Hemophilia 29, no. 1 (2023): 404-407. https://doi.org/10.1111/hae.14727.

MLA (9th ed.) Citation

Sidonio, Robert F., et al. "Pharmacokinetic Parameters of Recombinant Factor IX Fc Fusion Protein Are Not Influenced by Factor IX Antigen Levels in Subjects from the Phase 3 B‐LONG Trial." Haemophilia : The Official Journal of the World Federation of Hemophilia, vol. 29, no. 1, 2023, pp. 404-407, https://doi.org/10.1111/hae.14727.